Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) has closed the first tranche of its non-brokered private placement, issuing 5,811,600 units at $0.125 per unit for aggregate gross proceeds of $726,450. The company intends to use the net proceeds primarily for general working capital purposes. Insider participation, including by interim CEO Paula Muto, triggered related-party transaction disclosures under Multilateral Instrument 61-101. Investors may be watching for details on the anticipated second tranche closing.

Key Points

  • Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL)
  • First tranche of non-brokered private placement closed October 6, 2026, raising $726,450 gross proceeds
  • Units priced at $0.125 each; each unit includes one common share and one warrant exercisable at $0.25 for 12 months, with accelerated expiry if shares trade at or above $0.35 for 30 consecutive days
  • A second tranche is expected to close in the coming weeks, subject to regulatory approvals and customary closing conditions

Unit Structure and Warrant Acceleration Terms

Each of the 5,811,600 units issued consists of one common share and one warrant exercisable at $0.25 per share for twelve months following the October 6, 2026 closing date. The company has incorporated an acceleration provision: if the closing price of Apptly shares on the CSE equals or exceeds $0.35 for thirty consecutive trading days, the company may accelerate the warrant expiry to thirty days following a subsequent news release announcement. Warrants not exercised before any accelerated expiry date will lapse entirely. All securities issued carry a hold period of four months and one day under applicable Canadian securities laws.

Insider Participation Triggers MI 61-101 Disclosures

Interim Chief Executive Officer Paula Muto subscribed for 1,071,600 units for gross proceeds of $133,950, while an existing 10% shareholder subscribed for 800,000 units for gross proceeds of $100,000. The company states that both participants qualify as insiders, making their involvement a related-party transaction under Multilateral Instrument 61-101. Apptly disclosed that the issuance is exempt from formal valuation requirements under Subsection 5.5(b) and from minority approval requirements under Subsection 5.7(1)(b) of MI 61-101, as the fair market value of the transaction was below $2,500,000.

Finder's Fees and Use of Proceeds from the APPT Offering

In connection with closing the first tranche, Apptly paid finder's fees totalling $2,975 and issued 23,800 non-transferable broker warrants to an arm's-length party, each exercisable at $0.25 per share for twelve months from the closing date and subject to the same acceleration provisions. The release states that net proceeds will be directed primarily toward general working capital. Apptly operates UberDoc, a direct-pay healthcare marketplace connecting patients with board-certified specialists across more than 55 specialties in all 50 U.S. states. The immediate share price impact was not clear from available public information.